FHL-701

N/A

Report date: 2023/09/04 17:40:10

Base Information

Drug NameFHL-701
Drug Alias NameFHL-701
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionInterleukin-12 subunit beta inhibitors
TargetsInterleukin-12 subunit beta
Therapy Area/IndicationsAlzheimer DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHong Kong
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesForest Hills Lab
China Registration ClassN/A

Develop Information

Active CompaniesForest Hills Lab
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A